BACKGROUND/AIMS: Little is known about the direct costs of individuals with Mild Cognitive Impairment (MCI). This study investigates the direct costs associated with MCI according to recent diagnostic criteria from a societal perspective. METHODS: Four hundred and fifty-two primary care patients aged 75+ from Leipzig, Germany, were investigated in face-to-face interviews regarding MCI according to the current diagnostic criteria of the International Working Group on MCI, resource utilisation and costs (questionnaire of service utilisation and costs), as well as chronic medical illness (Chronic Disease Score). Resource utilisation was monetarily valued using 2004/2005 prices. RESULTS: Mean annual direct costs were 4,443 euro for patients with MCI (n=39) and 3,814 euro for patients without MCI (n=413) (p=0.34). Looking at the cost components, patients with and without MCI only significantly differed regarding pharmaceutical costs (1,210 euro vs 1,062 euro; p<0.05) not caused by antidementive drugs. CONCLUSION: Direct costs of individuals having MCI are not significantly increased in comparison to direct costs of individuals without cognitive deficits.
BACKGROUND/AIMS: Little is known about the direct costs of individuals with Mild Cognitive Impairment (MCI). This study investigates the direct costs associated with MCI according to recent diagnostic criteria from a societal perspective. METHODS: Four hundred and fifty-two primary care patients aged 75+ from Leipzig, Germany, were investigated in face-to-face interviews regarding MCI according to the current diagnostic criteria of the International Working Group on MCI, resource utilisation and costs (questionnaire of service utilisation and costs), as well as chronic medical illness (Chronic Disease Score). Resource utilisation was monetarily valued using 2004/2005 prices. RESULTS: Mean annual direct costs were 4,443 euro for patients with MCI (n=39) and 3,814 euro for patients without MCI (n=413) (p=0.34). Looking at the cost components, patients with and without MCI only significantly differed regarding pharmaceutical costs (1,210 euro vs 1,062 euro; p<0.05) not caused by antidementive drugs. CONCLUSION: Direct costs of individuals having MCI are not significantly increased in comparison to direct costs of individuals without cognitive deficits.
Authors: Carolyn W Zhu; Mary Sano; Steven H Ferris; Peter J Whitehouse; Marian B Patterson; Paul S Aisen Journal: J Am Geriatr Soc Date: 2013-02-15 Impact factor: 5.562
Authors: Linda Teri; Glenise McKenzie; Rebecca G Logsdon; Susan M McCurry; Salli Bollin; Jennifer Mead; Heather Menne Journal: Gerontologist Date: 2012-01-12
Authors: Cynthia L Leibson; Kirsten Hall Long; Jeanine E Ransom; Rosebud O Roberts; Steven L Hass; Amy M Duhig; Carin Y Smith; Jane A Emerson; V Shane Pankratz; Ronald C Petersen Journal: Alzheimers Dement Date: 2015-04-06 Impact factor: 21.566
Authors: Niels Janssen; Ron L Handels; Anders Wimo; Riitta Antikainen; Tiina Laatikainen; Hilkka Soininen; Timo Strandberg; Jaakko Tuomilehto; Miia Kivipelto; Silvia M A A Evers; Frans R J Verhey; Tiia Ngandu Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: Ingmar Schäfer; Hanna Kaduszkiewicz; Christine Mellert; Christin Löffler; Achim Mortsiefer; Annette Ernst; Carl-Otto Stolzenbach; Birgitt Wiese; Heinz-Harald Abholz; Martin Scherer; Hendrik van den Bussche; Attila Altiner Journal: BMJ Open Date: 2018-01-23 Impact factor: 2.692
Authors: William Perry; Laura Lacritz; Tresa Roebuck-Spencer; Cheryl Silver; Robert L Denney; John Meyers; Charles E McConnel; Neil Pliskin; Deb Adler; Christopher Alban; Mark Bondi; Michelle Braun; Xavier Cagigas; Morgan Daven; Lisa Drozdick; Norman L Foster; Ula Hwang; Laurie Ivey; Grant Iverson; Joel Kramer; Melinda Lantz; Lisa Latts; Shari M Ling; Ana Maria Lopez; Michael Malone; Lori Martin-Plank; Katie Maslow; Don Melady; Melissa Messer; Randi Most; Margaret P Norris; David Shafer; Nina Silverberg; Colin M Thomas; Laura Thornhill; Jean Tsai; Nirav Vakharia; Martin Waters; Tamara Golden Journal: Arch Clin Neuropsychol Date: 2018-09-01 Impact factor: 2.813